ALMS vs BIIB: Which Stock is Better?
Side-by-side comparison of Alumis Inc and Biogen Inc in 2026
ALMS
Alumis Inc
$26.34
BIIB
Biogen Inc
$190.48
Key Metrics Comparison
| Metric | ALMS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $3.50B | $27.95B | BIIB |
| P/E Ratio | N/A | 21.40 | BIIB |
| EPS (TTM) | $N/A | $8.90 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 100.0% | 78.9% | ALMS |
Analyze ALMS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALMS or BIIB a better investment?
Comparing ALMS and BIIB: Alumis Inc has a market cap of $3.50B while Biogen Inc has $27.95B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALMS and BIIB?
ALMS (Alumis Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALMS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALMS or BIIB?
ALMS has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: ALMS or BIIB?
Alumis Inc (ALMS) has higher gross margins at 100.0% compared to 78.9% for BIIB.
Which is the larger company: ALMS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.95B compared to $3.50B for ALMS.
Should I buy ALMS or BIIB in 2026?
Both ALMS and BIIB have investment merit. ALMS trades at $26.34 while BIIB trades at $190.48. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALMS and BIIB stock?
Key differences: Market Cap ($3.50B vs $27.95B), P/E Ratio (N/A vs 21.4x), Revenue Growth (0.0% vs -0.1%), Gross Margin (100.0% vs 78.9%).